Influence of 18F-fluorodeoxyglucose-positron emission tomography on computed tomography-based radiation treatment planning for oesophageal cancer

Australasian Radiology

Volumn 50, Issue 3, 2006, Pages 271-274

  Everitt, C ^a   Leong, T ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Oesophageal cancer; Positron emission tomography; Positron emission tomography computed tomography; Radiotherapy

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER THERAPY; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DATA ANALYSIS; ESOPHAGUS CANCER; GEOGRAPHY; HUMAN; MALE; METASTASIS; ODYNOPHAGIA; PRIORITY JOURNAL; TREATMENT PLANNING; TUMOR VOLUME; COMPUTER ASSISTED RADIOTHERAPY; ESOPHAGUS TUMOR; POSITRON EMISSION TOMOGRAPHY; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33744723190     PISSN: 00048461     EISSN: 14401673     Source Type: Journal    
DOI: 10.1111/j.1440-1673.2006.01578.x     Document Type: Article

References (20)

1. Thompson WM. Esophageal cancer. Int J Radiat Oncol Biol Phys 1983 9 : 1533 65.
2. Martenson JA Schild SE Haddock MG. Cancers of the gastrointestinal tract. In : Khan FM Potish RA eds Treatment Planning in Radiation Oncology. Williams and Wilkins, Baltimore, 1998 319 42.
3. Flamen P Lerut A Van Cutsem E et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000 18 : 3202 10.
4. Higashi K Ueda Y Ayabe K et al. FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features. Nucl Med Commun 2000 21 : 707 14.
5. Brucher BL Weber W Bauer M et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg 2001 233 : 300 309.
6. Kalff V Hicks RJ MacManus MP et al. Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study. J Clin Oncol 2001 19 : 111 18.
7. Weber WA Ott K Becker K et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 2001 19 : 3058 65.
8. Flamen P Van Cutsem E Lerut A et al. Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol 2002 13 : 361 8.
9. Kato H Kuwano H Nakajima M et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer 2002 94 : 921 8.
10. Miller TR Grigsby PW. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys 2002 53 : 353 9.
11. Downey RJ Akhurst T Ilson D et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol 2003 21 : 428 32.
12. Kiffer JD Berlangieri SU Scott AM et al. The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer 1998 19 : 167 77.
13. Munley MT Marks LB Scarfone C et al. Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects. Lung Cancer 1999 23 : 105 14.
14. Nestle U Walter K Schmidt S et al. 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. Int J Radiat Oncol Biol Phys 1999 44 : 593 7.
15. Vanuytsel LJ Vansteenkiste JF Stroobants SG et al. The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 2000 55 : 317 24.
16. Erdi YE Rosenzweig K Erdi AK et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 2002 62 : 51 60.
17. Mah K Caldwell CB Ung YC et al. The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study. Int J Radiat Oncol Biol Phys 2002 52 : 339 50.
18. Nishioka T Shiga T Shirato H et al. Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys 2002 53 : 1051 7.
19. Scarfone C Lavely WC Cmelak AJ et al. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med 2004 45 : 543 52.
20. Bradley J Thorstad WL Mutic S et al. Impact of FDG-PET on radiation therapy volume delineation in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2004 59 : 78 86.